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Abstract
Promyelocytic leukemia protein (PML) has antiviral functions and many viruses encode gene products that disrupt PML
nuclear bodies (PML NBs). However, evidence of the relevance of PML NB modification for viral pathogenesis is limited and
little is known about viral gene functions required for PML NB disruption in infected cells in vivo. Varicella-zoster virus (VZV)
is a human alphaherpesvirus that causes cutaneous lesions during primary and recurrent infection. Here we show that VZV
disrupts PML NBs in infected cells in human skin xenografts in SCID mice and that the disruption is achieved by open
reading frame 61 (ORF61) protein via its SUMO-interacting motifs (SIMs). Three conserved SIMs mediated ORF61 binding to
SUMO1 and were required for ORF61 association with and disruption of PML NBs. Mutation of the ORF61 SIMs in the VZV
genome showed that these motifs were necessary for PML NB dispersal in VZV-infected cells in vitro. In vivo, PML NBs were
highly abundant, especially in basal layer cells of uninfected skin, whereas their frequency was significantly decreased in
VZV-infected cells. In contrast, mutation of the ORF61 SIMs reduced ORF61 association with PML NBs, most PML NBs
remained intact and importantly, viral replication in skin was severely impaired. The ORF61 SIM mutant virus failed to cause
the typical VZV lesions that penetrate across the basement membrane into the dermis and viral spread in the epidermis was
limited. These experiments indicate that VZV pathogenesis in skin depends upon the ORF61-mediated disruption of PML
NBs and that the ORF61 SUMO-binding function is necessary for this effect. More broadly, our study elucidates the
importance of PML NBs for the innate control of a viral pathogen during infection of differentiated cells within their tissue
microenvironment in vivo and the requirement for a viral protein with SUMO-binding capacity to counteract this intrinsic
barrier.
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Introduction
Promyelocytic leukemia nuclear bodies (PML NBs), also called
nuclear domain 10 (ND10) bodies, are spherical nuclear structures
that are present in most mammalian cells [1]. PML protein is the
essential major component and recruits other proteins, such as
Sp100, Daxx, SUMO1, CBP and p53 [2]. PML NBs are
associated with many cellular processes, including transcription,
the DNA damage response, apoptosis and oncogenesis [1]. Under
normal conditions, the number of PML NBs varies depending on
cell type and differentiation status [3-5]. PML is also an interferon
(IFN)-inducible protein and IFN treatment increases the number
and size of PML NBs [6]. PML NBs have been shown to
contribute to innate defenses against a broad range of viruses [7].
In turn, many viruses encode products that modify or eliminate
PML NBs in cultured cells [7]. However, few studies have
investigated the role of PML NBs in viral pathogenesis or
mechanisms by which they are modified during viral infection in
vivo [8,9].
Varicella-zoster virus (VZV) is the etiologic agent of varicella
(chickenpox) and herpes zoster (shingles) and causes characteristic
cutaneous lesions in both diseases [10]. VZV is an alphaherpes-
virus closely related to herpes simplex virus (HSV) 1 and 2 [10].
PML is known to interfere with HSV early viral gene transcription
and it is important for the antiviral effects of IFNs on HSV
[11,12]. PML knock-down and over-expression experiments
indicate that PML is also involved in restricting VZV replication
[9,13]. In HSV-infected cells, the ICP0 protein triggers the
proteasome-dependent degradation of sumoylated PML and
Sp100 through ubiqutin E3 ligase activity mediated by its RING
domain [14-17]. In contrast to HSV, VZV does not degrade PML
protein [9,13], although it does disrupt PML NBs, causing a
reduction of approximately five-fold in PML NB frequencies in
vitro [9]. Our recent work demonstrated that the PML NBs that
persist in VZV infected cells in vitro and in skin and dorsal root
ganglia (DRG) in vivo have the capacity to sequester newly formed
nucleocapsids [9]. The entrapment of VZV capsids in these
nuclear PML cages depended upon an interaction between PML
and the ORF23 capsid protein and acted as an intrinsic antiviral
host defense [9].
The VZV ortholog of HSV ICP0 is ORF61 [10]. Like ICP0,
ORF61 colocalizes with PML NBs shortly after virus entry and
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domain is intact [18,19]. The ORF61 RING domain also exhibits
E3 ligase activity in vitro [19,20]. Besides these functions, ORF61
has been shown to act as a transactivator to regulate a number of
viral and cellular promoters in transient transfection assays and
contributes to the optimal expression of VZV glycoprotein E
during virus replication in cultured cells [21-23]. ORF61 is
essential for VZV replication in vitro; deleting ORF61 is not
compatible with recovery of infectious virus and truncating
ORF61 or severely limiting its expression by mutating promoter
elements markedly impairs virus replication [22-24].
Although VZV is a highly human-restricted virus, its patho-
genesis can be investigated using xenografts of human skin, thymus
and DRG in severe combined immunodeficiency (SCID) mice
[25,26]. The evaluation of VZV recombinant viruses with genetic
mutations in the SCID mouse model makes it possible to analyze
mechanisms of virus-host cell interactions in differentiated cells in
vivo and to determine whether putative functional motifs in viral
proteins or promoters contribute to the capacity of the virus to
overcome intrinsic barriers. Targeted mutations in the viral
genome that have little or no effect in VZV replication in cultured
cells can disrupt functions that are critical for pathogenesis [27].
By evaluating ORF61 promoter mutants in the skin xenograft
model, we demonstrated that ORF61 is necessary for VZV skin
pathogenesis [23], but the reason for this ORF61 requirement was
not defined. In this study, our goal was to investigate the functional
elements of ORF61 protein, which are required for interaction
with PML NBs in differentiated cells infected in vivo and the
contribution of this interaction to VZV infection in skin using the
xenograft model.
To identify potential ORF61 functional domains, we analyzed
the ORF61 sequence and found that it has three putative small
ubiquitin-like modifier (SUMO)-interacting motifs (SIMs) in
addition to the conserved RING domain. SIMs have been
identified in a number of proteins and have a hydrophobic core,
consisting of 3-4 aliphatic residues (V/L/I-x-V/L/I-V/L/I or V/
L/I-V/L/I-x-V/L/I; ‘x’ means any amino acid), which are
typically flanked by a stretch of negatively charged amino acids
[28-30]. Structural studies indicate that the motif has an extended
configuration and is embedded in the groove formed between the
a-helix and the b-strand of SUMO [31]. PML protein contains a
SIM and the binding through the SIM to sumoylated PML is
considered to be the nucleation event for recruitment of other
sumoylated and SIM-containing proteins [32]. In support of this
model, SIMs in cellular proteins, including Daxx, RNF4 and
Sizn1 and in the Kaposi’s sarcoma herpesvirus (KSHV) LANA2
protein, are necessary for their association with or modification of
PML NBs [33-36].
This study was designed to investigate whether the putative
SIMs that we identified in ORF61 mediated ORF61 binding to
SUMO and if so, whether these SIMs were important for ORF61
association with PML NBs and for the disruption of PML NB in
vitro. These questions were addressed by mutagenesis of the SIMs
in ORF61 plasmid constructs or in ORF61 in the context of the
VZV genome. We then examined the significance of the ORF61
SUMO-binding capacity for PML NB association and dispersal in
differentiated skin cells using the SCID mouse model. In summary,
we have demonstrated that ORF61 has a SIM-mediated SUMO-
binding capacity which is necessary for its capacity to target and
disrupt PML NBs in differentiated skin cells in vivo and that this
ORF61 SIM-mediated function is a critical determinant of the
pathogenic potential of VZV in skin.
Results
ORF61 is a SUMO-binding protein and binds to SUMO1
through conserved SUMO-interacting motifs (SIMs)
By sequence analysis, we observed that ORF61 has three
putative SIMs; two are located in the N-terminus near the RING
domain (designated as SIM-N1 and SIM-N2) and a third is in the
C-terminus (designated as SIM-C) (Fig. 1A). Of interest, one or
more putative SIMs are also present in the ORF61 orthologs of
other alphaherpesviruses (Table 1).
We first investigated whether the ORF61 SIMs had the
functional capacity to mediate ORF61 binding to SUMO. In
GST pull down assays, ORF61 expressed in VZV-infected cells
and in transiently transfected cells bound to GST-SUMO1 and
also to GST-SUMO2, although less efficiently; non-specific
binding to GST was not detected (Fig. 1B). The ORF61 SIMs
were then mutated by alanine substitutions in the ORF61 plasmid,
resulting in mSIM-N (both SIM-N1 and SIM-N2 disrupted),
mSIM-C (SIM-C disrupted), and mSIM-N&C (all three sites
disrupted). When these SIM mutants were evaluated with GST
pull down assay, the SUMO1 binding capacity of mSIM-N was
similar to ORF61 whereas binding of mSIM-C was reduced
markedly and mSIM-N&C did not bind to SUMO1 (Fig. 1C).
ORF61 SIMs are essential for ORF61 association with PML
NBs and ORF61-mediated PML NB dispersal in
transfected cells
Since ORF61 is expressed and colocalizes with PML NBs at
very early times in VZV-infected cells [18], we investigated the
pattern of ORF61 association with PML NBs in transfected
melanoma cells. As expected, distinct ORF61 nuclear puncta were
observed in cells with low levels of expression and most colocalized
with PML NBs (Fig. 2A, panel I). The effect of the ORF61 SIM
mutations on association with PML NBs was then evaluated. The
localization of mSIM-N puncta with PML NBs was similar to
ORF61 (Fig. 2A, panel II); mSIM-C nuclear puncta were found in
only a few cells but also colocalized with PML NBs (Fig. 2A, panel
III). In contrast, mSIM-N&C nuclear puncta, also found in only a
few cells, did not colocalize with PML NBs (Fig. 2A, panel IV).
Author Summary
PML nuclear bodies (PML NBs) are spherical nuclear
structures that are present in most human and animal
cells. These bodies contribute to anti-viral defense and
therefore many viruses have developed strategies to
disrupt them. This interaction has been demonstrated for
a number of viruses in cultured cells but little is known
about these processes in differentiated cells within human
tissues. Varicella-zoster virus (VZV) is a human alphaher-
pesvirus that causes chicken pox and shingle lesions in
skin. Here we show that VZV disrupts PML NBs in
epidermal and dermal cells in skin tissues implanted
subcutaneously in immunodeficient mice. We found that
PML NB dispersal is mediated by VZV ORF61 protein and is
required for VZV cell to cell spread and lesion formation in
skin. The ability of ORF61 to disrupt PML NBs depends on
its capacity to bind to SUMO1 protein, which is conjugated
to PML and other proteins within PML NBs. To our
knowledge, our study provides the first evidence of PML
NB modification through the SUMO-binding function of a
viral protein, VZV ORF61, and the importance of this
molecular mechanism for virus-induced PML NB disruption
in differentiated cells infected within their tissue microen-
vironment in vivo.
PML NB Disruption by VZV ORF61 in Skin Infection
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characterized RING/E3 ligase domain [19,20] showed that this
DRING mutant formed large bright nuclear puncta, most of
which were associated with PML NBs (Fig. 2A, panel V). Thus, in
contrast to the ORF61 SIMs, the ORF61 RING domain was not
required for PML NB association.
Next, the capacity of ORF61 and SIM mutants to disperse PML
NBs was examined. In cells with abundant ORF61 expression,
punctate staining was less evident, the protein was distributed
more diffusely in the nucleus and the number of PML NBs was
decreased significantly compared to cells in the same monolayer
that did not express ORF61 (Fig. 2B, panel I). The PML NB
frequency in ORF61-positive cells was 0.9760.08 (N=224),
which was a 4.7-fold reduction (p,0.0001) compared to mock-
transfected cells (4.5360.17, N=245) (Fig. 2C). PML NBs were
also obviously reduced in cells expressing abundant mSIM-N
compared to untransfected cells but were better preserved in cells
with abundant mSIM-C or mSIM-N&C (Fig. 2B, panel II to IV).
The DRING mutant had no obvious effect on PML NBs (data not
shown), which was consistent with a previous report using Sp100
as a PML NB marker [19]. As determined by quantification of
PML NB frequencies in these cells, the capacity of mSIM-N to
disperse PML NBs was slightly less than ORF61, the effect of
mSIM-C was reduced significantly and mSIM-N&C was com-
pletely ineffective (Fig. 2C). The PML NB frequency in mSIM-
N&C-expressing cells was comparable to that in cells expressing
ORF61 DRING and mock-transfected cells (Fig. 2C).
Taken together, these experiments demonstrated that when
expressed in the absence of other viral proteins, ORF61 targets
and disrupts a majority of PML NBs and that the ORF61 SIMs
were necessary and as important as the RING domain for
ORF61-mediated dispersal of PML NBs. As a single motif, the C-
terminal SIM was the most important for ORF61 SUMO-binding
and PML NB dispersal but all three SIMs were required to achieve
both the association with PML NBs and their efficient dispersal.
To investigate the effect of ORF61 on PML protein levels,
ORF61 was co-expressed with each of six PML isoforms in
melanoma cells for 24 h and cells were then treated with the
proteasome inhibitor MG132 for 6 h. As shown for PML IV, the
PML protein level was unchanged between mock-treated and
MG132-treated cells (Fig. 2D, lanes 5 & 6). Similar results were
obtained with PML isoforms I-III, V and VI (data not shown).
ORF61 accumulated abundantly (Fig. 2D), confirming its rapid
turnover [20]. These data suggested that, unlike HSV ICP0,
ORF61 does not degrade PML protein despite its conserved
RING domain and E3 ligase activity, which is consistent with the
persistence of PML protein in VZV-infected cells [9,13].
ORF61 SIMs are dispensable for other ORF61 functions
We next investigated the potential role of the ORF61 SIMs in
other ORF61 functions. ORF61 is known to regulate expression of
the essential VZV glycoprotein, gE, through a RING domain-
dependent mechanism [21,37]. However, disrupting the ORF61
SIMs did not alter activation of either the gE or the ORF61
promoters (Fig. 3A). Since VZV inhibits NF-kB activation [38], we
also investigated ORF61 regulation of the NF-kB promoter. Of
interest, NF-kB activation by TNF-a was suppressed by ORF61 in
a dose-dependent manner and again, this function required the
RING domain but not the SIMs (Fig. 3B and 3C). Thus, while the
RING domain is essential for all of these ORF61 functions, the
SIMs are specifically needed for ORF61 association with and
dispersal of PML NBs. These data also suggest that the SIM
mutations did not result in aberrant folding of ORF61 protein,
which would be expected interfere with these other functions.
Table 1. Prediction of putative SIMs in ORF61 orthologs of
other alphaherpesviruses.
Virus Putative SIMs
HSV-1
164IVGV
167,
176IPIV
179,
331VGVV
334,
651VVAL
654,
667IPIL
670,
681VVLV
684
BHV-1
173LPLL
176,
252LLFV
255,
489VIDL
492
EHV-1
142LALV
145,
309IIDL
312,
357IICL
360,
435VVLV
438
MHV-1
423LVGL
426,
447IVDL
450
FHV-1
335LDLT
338,
353VIAL
356
MDV-1
147VALL
150
PRV
183IVEI
186,
402IDLT
405
HSV-1: herpes simplex 1; BHV-1: bovine herpesvirus 1; EHV-1: equid herpesvirus
1; MHV-1: macropodid herpesvirus 1; FHV-1: felid herpesvirus 1; MDV-1: Marek’s
disease virus type 1; PRV: pseudorabies virus. The numbers in superscript indi-
cate the amino acid position of each SIM in the protein.
doi:10.1371/journal.ppat.1002157.t001
Figure 1. ORF61 binds to SUMO1/2 through conserved SUMO-
interacting motifs (SIMs). (A) Schematic representation of the ORF61
protein sequence (amino acids 1-467). The diagonal shaded box
indicates the RING domain; filled boxes indicate the three conserved
SIMs; the sequences of the SIM hydrophobic core are highlighted by
italics and underlined. The numbers in superscript show the amino acid
positions of the SIMs in ORF61. (B) Binding of ORF61 (from VZV-infected
or ORF61-transfected cell lysates) to SUMO1/2 in GST pull down.
Western blot with ORF61 antibody shows the ORF61 proteins bound to
SUMO1/2; amido black (AB) staining shows the amount of GST and GST-
SUMO1/2 proteins used for binding. (C) Binding of ORF61 SIM mutant
proteins from transfected cell lysates to SUMO1 in GST pull down.
Western blot shows the amount of ORF61 or SIM mutant proteins
bound to SUMO1 and the amount of proteins in the input lysates;
amido black (AB) staining shows amount of GST and GST-SUMO1
proteins used for binding.
doi:10.1371/journal.ppat.1002157.g001
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infected cells but are not required for VZV replication in
vitro
In order to assess the contributions of the ORF61 SIMs to PML
NB association and dispersal in infected cells and to VZV
replication, we made three VZV recombinants that contained the
same ORF61 SIM mutations as in the ORF61 mutant plasmids.
These mutants were designated as pOka-mSIM-N, pOka-mSIM-
C and pOka-mSIM-N&C, respectively. Evaluation of the
SUMO1-binding capacity of the ORF61 SIM mutant proteins
produced in infected cells with the GST pull-down assay showed
that interactions of mSIM-C and mSIM-N&C with SUMO1 were
almost undetectable whereas mSIM-N binding was diminished
only slightly (Fig. 4A), confirming the SIM-mediated binding of
ORF61 to SUMO1 as was observed in transfection experiments.
Treating cells infected with pOka and ORF61 SIM mutants with
MG132 showed that the intracellular processing of the ORF61
SIM mutant proteins was indistinguishable from ORF61 (Fig. 4B),
again suggesting that these mutant proteins were not likely to have
major structural changes and that their reduced SUMO-binding
capacity was attributable to disruption of the functional SIMs.
When the effect of the SIM mutations on ORF61 association
with PML NBs was examined in melanoma cells at 6 h after
infection, all three ORF61 SIM mutants formed minute ORF61-
positive nuclear puncta, colocalizing with PML NBs (Fig. 5A).
After 24 h, PML NBs were reduced substantially in cells infected
with pOka-mSIM-N as well as pOka, whereas disruption of PML
NBs was considerably less in pOka-mSIM-C- and pOka-mSIM-
N&C-infected cells (Fig. 5B). Quantitative analysis showed that
cells infected with pOka-mSIM-C retained 2.5-fold more PML
NBs compared to pOka-infected cells; the PML NB frequency in
cells infected with pOka-mSIM-N&C was equivalent to that in
mock-infected cells (Fig. 5C, left panel). Similar patterns were
observed in HELFs (Fig. 5C, right panel). These experiments
indicate that the capacity of ORF61 to bind to SUMO1 through
its SIMs correlates with how efficiently it disrupts PML NBs in
VZV-infected cells. The preservation of some colocalization of the
mSIM-N&C protein with PML NBs in infected cells, which was
not observed under transfection conditions, suggests that another
viral factor(s) or a virus-induced factor(s) may also contribute to
ORF61 association with PML NBs. Since neither pOka infection
nor ORF61 expression alters the levels of endogenous PML
protein (9, Fig. 2D), it was expected that PML levels in melanoma
cells and HELFs infected with the ORF61 SIM mutants would be
unchanged (Fig. 5D).
Despite the compromised effect on PML NB dispersal, the
growth kinetics of all three ORF61 SIM mutants was similar to
pOka in melanoma cells, as determined by infectious focus assay
(Fig. 5E). Yields of ORF61 SIM mutants and pOka were also
comparable in HELFs (data not shown). Thus, the dispersal of
Figure 2. ORF61 SIMs are essential for ORF61 association with PML NBs and PML NB disruption in transfected cells. (A) Confocal
microscopy of ORF61-, SIM mutants-, or nRING-transfected melanoma cells that were stained for ORF61 (red), PML (green), and nuclei (blue). ORF61-
positive puncta in cells expressing low level of ORF61 wild-type and mutant proteins are indicated by white arrows and their associations with PML
NBs are shown. The insets are zoom-in images of the white square area. Scale bars: 5 mm. (B) Confocal microscopy of ORF61- or SIM mutant-
transfected melanoma cells that were stained for ORF61 (red), PML (green), and nuclei (blue). Nuclei with abundant expression of ORF61 or SIM
mutant proteins are outlined by dashed ovals. Scale bars: 20 mm. (C) PML NB frequencies (mean6SEM) in cells expressing abundant ORF61, nRING, or
SIM mutant proteins (Mock, N=245; WT, N=224; mSIM-N, N=234; mSIM-C, N=237; mSIM-N&C, N=238; DRING, N=201). (D) The effect of ORF61 on
the PML IV protein level. Melanoma cells transfected with PML IV expressing plasmid alone or together with pcDNA-ORF61 were treated with 10 mM
MG132 for 6 h at 24 h post-transfection. Western blots with ORF61, PML, and tubulin antibodies are shown.
doi:10.1371/journal.ppat.1002157.g002
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VZV replication in permissive cells in vitro.
ORF61 SIMs are required for VZV pathogenesis in skin in
vivo
When the ORF61 SIM mutants were evaluated in human skin
xenografts in SCID mice, the infectious virus yield of pOka-
mSIM-N was similar to pOka, while the replication of pOka-
mSIM-C was delayed slightly, with virus yields that were lower
than pOka at day 10 (p,0.05) but had increased by day 21
(p,0.05) (Fig. 6A). Infectious virus was recovered from 5 of 6 or all
6 xenografts inoculated with pOka, pOka-mSIM-N or pOka-
mSIM-C. In contrast, pOka-mSIM-N&C replication in skin was
severely impaired. pOka-mSIM-N&C was recovered from only 4
of 6 inoculated xenografts at day 10 and 3 of 6 at day 21. Titers
from the xenografts that yielded pOka-mSIM-N&C were ,30-
fold lower than pOka at day 10 (p,0.001) and ,500-fold lower at
day 21 (p,0.001) (Fig. 6A).
Analysis of skin tissue sections showed that pOka formed the
usual large necrotic VZV lesions that penetrate across the basal
cell layer into the dermis whereas pOka-mSIM-N&C lesions were
very small and restricted to the epidermis (Fig. 6B). It is important
to note that PML NBs were prominent in skin cells in mock-
infected xenografts, with the highest frequency being found in cells
of the basal layer (Fig. 6C, upper panels). However, many more
PML NBs were present in the uninfected cells present within skin
xenografts that were infected with pOka or pOka-mSIM-N&C,
compared to these mock-infected tissues (Fig. 6C, middle and
lower panels and Fig. S1). Quantification of two skin xenografts
that were infected with pOka and two infected with pOka-mSIM-
N&C showed 3.8-6.6 fold increase in PML NB frequency in
uninfected cells respectively, compared with the mock-infected
xenograft (Fig. 6D); the PML NB frequencies did not differ
significantly between xenografts inoculated with pOka or pOka-
mSIM-N&C (Fig. 6D). Since skin cells dramatically up-regulate
IFN production in response to VZV infection in vivo and PML is
IFN-inducible [6,39], our findings suggest that the innate IFN
response increases PML NB numbers in dermal and epidermal
cells, reinforcing a pre-existing barrier to VZV spread.
ORF61 SIMs are required for ORF61 association with PML
NBs and their dispersal in skin cells
The small epidermal lesions and the failure of pOka-mSIM-
N&C to create lesions that extend across the basal layer suggested
that VZV spread from cell to cell in skin might depend on ORF61
SIM-mediated PML NB disruption. To investigate this possibility,
we examined the pattern of ORF61/PML NB association and the
PML NB frequencies in skin cells infected with pOka and the
Figure 3. ORF61 SIMs are dispensable for other ORF61
functions. (A) The effect of ORF61 SIM mutants on gE promoter (left
panel) and ORF61 promoter (right panel). Luciferase assays were
performed on melanoma cells transfected with gE promoter or ORF61
promoter construct and pcDNA constructs expressing ORF61 DRING
mutant and SIM mutants. (B) NF-kB suppression by ORF61 and DRING
mutant. Luciferase assays were performed on melanoma cells that were
cotransfected with NF-kB reporter plasmid and increasing amounts (10-
250 ng) of pcDNA-ORF61 (left panel) or pcDNA-ORF61(DRING) (right
panel) and then treated with TNF-a. (C) NF-kB suppression by ORF61
SIM mutants. Luciferase assays were performed on melanoma cells that
were transfected with NF-kB reporter plasmid and a fixed amount
(250 ng) of pcDNA constructs expressing ORF61 SIM mutants and then
treated with TNF-a. The graphs show the relative luciferase units (firefly
luciferase units normalized with renilla luciferase units).
doi:10.1371/journal.ppat.1002157.g003
Figure 4. ORF61 SIMs are essential for the SUMO-binding capacity of ORF61 expressed in VZV-infected cells. (A) Binding of ORF61 SIM
mutant proteins produced from infected cells to SUMO1 in GST pull down. Western blot with ORF61 antibody shows the ORF61 and SIM mutant
proteins bound to SUMO1/2; amido black (AB) staining shows GST and GST-SUMO1/2 levels. (B) The processing of ORF61 and SIM mutant proteins in
infected cells. Melanoma cells infected with pOka and ORF61 SIM mutant viruses were mock-treated or treated with MG132. Western blots of ORF61,
IE63 (a VZV immediate early protein), and tubulin are shown. IE63 serves as the control for VZV infection. UI indicates uninfected cells.
doi:10.1371/journal.ppat.1002157.g004
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(A) Confocal microscopy of melanoma cells that were infected with pOka and ORF61 SIM mutants for 6 h and stained for ORF61 (red), PML (green),
and nuclei (blue). The images show association of puncta (indicated by white arrows) formed by ORF61 and SIM mutant proteins with PML NBs. Scale
bars: 5 mm. (B) Confocal microscopy of melanoma cells that were infected with pOka and ORF61 SIM mutants for 24 h and stained for ORF61 (red),
PML (green), and nuclei (blue). The images show PML NB dispersal in pOka- or SIM mutant-infected cells. Infected nuclei with abundant expression of
ORF61 or SIM mutant proteins are outlined by dashed ovals. Scale bars: 10 mm. (C) PML NB frequencies (mean6SEM) in pOka/ORF61 SIM mutants-
infected melanoma cells (Mock, N=213; pOka, N=206; mSIM-N, N=212; mSIM-C, N=202; mSIM-N&C, N=232) and HELFs (Mock, N=227; pOka,
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with PML NBs were evident in the newly infected cells located at
the margins of pOka skin lesions (Fig. 7A, panel I). pOka-mSIM-
N&C also formed distinct ORF61-positive nuclear puncta but in
contrast to pOka, the pattern of their association with PML NBs
was heterogenous in individual cells (Fig. 7A, panel II-IV). Skin
cells that had mSIM-N&C puncta could be categorized into three
groups: those in which either all or some puncta colocalized with
PML NBs (Fig. 7A, panel II and III) and those in which none
colocalized with PML NBs (Fig. 7A, panel IV). When these
associations were quantitated in the skin cell nuclei that had
ORF61 or mSIM-N&C puncta, colocalization of ORF61 with
PML NBs was observed in 100% of pOka-infected cells (N=47)
whereas only 35% of pOka-mSIM-N&C-infected cells (N=46)
showed any colocalization of ORF61 with PML NBs (p,0.0001)
(Fig. 7B, left panel). Analyzing these data based on total numbers
of ORF61 positive puncta in infected cell nuclei showed that 89%
of pOka ORF61 puncta (N=167) were associated with PML NBs
compared to only 25% of mSIM-N&C puncta (N=202)
(p,0.0001) (Fig. 7B, right panel).
Next, the frequency of PML NBs in skin cells infected with
pOka and the ORF61 SIM mutants was assessed. ORF23, a VZV
nucleocapsid protein, was used as a marker for infected cells as
abundant ORF23 protein indicates a later stage of VZV infection
[10]. Only infected cells with intact nuclear membranes were
analyzed to exclude those in which VZV had induced necrosis.
Figure 6. ORF61 SIMs are critical for VZV virulence in skin. (A) Replication of pOka and ORF61 SIM mutant viruses in human skin xenografts in
SCID mice (inoculum: ,8610
4 PFU/xenograft). The graph shows the mean titer6SEM of xenografts that yielded viruses at 10 and 21 days post-
infection. *, p,0.05; ***, p,0.001; vs pOka (two-way ANOVA). (B) Lesions in skin xenografts infected with pOka- or pOka-mSIM-N&C for 21 days were
identified by VZV gE expression. Nuclei were stained with methyl green. Magnification, 5x. Structures of epidermis [E] and dermis [D] are indicated. (C)
Confocal microscopy of uninfected cells from mock-infected skin xenografts (upper panels) and pOka- or pOka-mSIM-N&C-infected skin xenografts
(middle and lower panels). These skin sections were stained for PML proteins (green) and nuclei (blue). Epidermal and dermal layers are indicated.
Middle and right images of each panel are zoom-in of the blue square area from the left image. Scale bars: 20 mm. (D) PML NB frequency
(mean6SEM) in uninfected basal cells from each of two skin xenografts infected with either pOka or pOka-mSIM-N&C was quantified and compared
with a mock-infected xenograft (number of nuclei examined: Mock, N=112; pOka#1, N=99; pOka#2, N=93; mSIM-N&C#1, N=109; mSIM-N&C#2,
N=85).
doi:10.1371/journal.ppat.1002157.g006
N=221; mSIM-N, N=235; mSIM-C, N=225; mSIM-N&C, N=214). (D) Expression of PML in melanoma cells and HELFs that were infected by pOka or
ORF61 SIM mutants. VZV gE or IE63 serve as the control for VZV infection. (E) Replication of pOka and ORF61 SIM mutant viruses in melanoma cells
over 5 days. Each point represents mean6SEM of virus titers from three replicates.
doi:10.1371/journal.ppat.1002157.g005
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pOka- or pOka-mSIM-N&C-infected skin cells that were stained for ORF61 (red), PML (green), and nuclei (blue). The images show association of ORF61-
positive puncta with PML NBs in newly infected cells. Scale bars: 2.5 mm. (B) Quantitation of ORF61/PML NB association in pOka- or pOka-mSIM-N&C-
infected cells that had ORF61-positive puncta. The left panel shows percentage of cells that show/did not show ORF61 colocalization with PML NBs
(pOka, N=47; mSIM-N&C, N=46; ***, p,0.0001 by Chi-square). The right panel shows percentage of ORF61-positive puncta colocalized/not
colocalized with PML NBs (pOka, N=167; mSIM-N&C, N=202; ***, p,0.0001 by Chi-square). (C) Confocal microscopy of pOka- or pOka-mSIM-N&C-
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uninfected cells in the same section (Fig. 7C, left panels), while the
frequency of PML NBs in pOka-mSIM-N&C-infected cells was
similar to uninfected cells (Fig. 7C, right panels). Quantitative
analysis showed that more PML NBs (2.8-fold higher) were
preserved in pOka-mSIM-N&C-infected cells compared to pOka-
infected cells (pOka, 0.7160.07, N=153; pOka-mSIM-N&C,
1.9760.17, N=108; p,0.0001) (Fig. 7D). The PML NB
frequency in pOka-mSIM-C-infected cells (N=143) was equiva-
lent to pOka-infected cells (Fig. 7D). Both the detection of PML
expression and the frequency of PML NBs were similar in the
uninfected cells within xenografts infected either with pOka or
pOka-mSIM-N&C (Fig. 6C and 7E). This finding makes it
unlikely that the difference in PML NB frequency in skin cells
infected by these two viruses reflects a variation of PML NB
frequencies between individual xenografts.
Taken together, these results demonstrate that ORF61 SIMs
determine the capacity of VZV to target and disrupt PML NBs in
skin cells in vivo and indicate that VZV spread in skin depends on
this function.
Growth of ORF61 SIM mutant viruses in IFN-treated
cultured cells
Since these experiments in skin xenografts showed that pOka-
mSIM-N&C had a growth deficiency in vivo which was not
detectable in vitro and IFN-a, which induces PML, is present in
VZV-infected xenografts in vivo but is not produced by VZV-
infected cells in vitro [39,40], we evaluated the replication of pOka
and pOka-mSIM-N&C in cultured cells treated with IFN-a. The
number of PML NBs was increased by IFN-a treatment and as
expected, the PML NBs were disrupted by pOka but not by pOka-
mSIM-N&C (Fig. 8A and 8B). Nevertheless, IFN-a treatment had
a comparable effect on reducing pOka and pOka-mSIM-N&C
titers in melanoma cells and HELFs (Fig. 8C). However, even with
IFN treatment, PML NB frequencies in melanoma cells remained
significantly lower than frequencies observed in skin cells in vivo
(Fig. 8A). That pOka-mSIM-N&C was not differentially inhibited
in IFN-a treated cells when compared to pOka in vitro, in contrast
to the severely impaired growth of pOka-mSIM-N&C in skin
supports the significance of the very high frequencies of PML NBs
that are present in dermal and epidermal cells for limiting the
spread of VZV in vivo.
Growth of ORF61 SIM mutant viruses in non-proliferating
cells in vitro
Since VZV, like other viruses, replicates more efficiently in
proliferating cells, another reason for the defective growth of the
ORF61 SIM mutants in skin compared to cultured cells might be
fewer proliferating cells in vivo. Based on the expression of Ki67, a
proliferation marker [41], most HELFs were proliferating under
standard cell culture conditions whereas only a few skin cells from
mock- or VZV-infected xenografts were Ki67-positive (Fig. 9A
and 9B). No significant difference in Ki67 expression was observed
between uninfected cells in pOka- or pOka-mSIM-N&C-infected
xenografts (Fig. 9A). To further investigate whether the ORF61
SIMs confer an advantage for VZV replication in non-prolifer-
ating cells, the growth kinetics of pOka and pOka-mSIM-N&C
were compared in serum-starved HELFs. The percentage of Ki67-
positive HELFs was reduced to a minimal level by serum
starvation (Fig. 9B). However, titers of pOka-mSIM-N&C in
serum-starved HELFs were indistinguishable from pOka titers
(Fig. 9C). These results suggested that the difference in the
importance of ORF61 SIMs for VZV replication in skin compared
with cultured cells did not reflect an advantage for VZV
replication in non-proliferating cells that depends upon the
ORF61 SIMs.
Discussion
This study provides the first direct evidence of the importance of
PML NB disruption for the efficient replication of a viral pathogen
in differentiated human cells located within their usual tissue
microenvironment in vivo and of the requirement for the SUMO-
binding capacity of a viral protein, VZV ORF61, to counteract the
innate antiviral control mediated by PML NBs. This function is
critical in VZV skin infection because the persistence of the virus
in the human population depends upon its capacity to produce
cutaneous lesions that contain high concentrations of infectious
virus particles for transferring to susceptible individuals [10].
Notably, we found that PML NBs were highly abundant in human
skin cells, especially in the basal cell boundary between the
epidermis and the dermis. In the absence of functional ORF61
SIMs, these PML NBs were preserved and VZV infection was
severely impaired. Thus, our experiments indicate that VZV
pathogenesis in skin requires ORF61 association with and
dispersal of PML NBs and that this modification of host cell
nuclear structures depends upon ORF61 SIMs. We suggest that
PML NB-mediated control of VZV replication must be counter-
acted by ORF61 in order to produce the characteristic cutaneous
lesions of varicella and herpes zoster and that ORF61 SUMO-
binding capacity is necessary for this essential phase of the VZV
life cycle in the human host.
More generally, the finding that ORF61 has functional SIMs
that modulate PML NBs provides new evidence that non-covalent
SIM-SUMO interactions can alter the structure and dynamics of
PML NBs [32-36]. Importantly, the evaluation of VZV ORF61
SIM-deficient mutants in skin xenografts shows that this SIM-
dependent effect on PML NBs occurs in differentiated cells within
tissues in vivo. To our knowledge, ORF61 is the first example
showing that a viral RING finger protein has functional SIMs, like
those that are present in cellular RING finger proteins, such as
RNF4, which is involved in PML degradation [34]. Of interest,
the less conserved SIM-C motif ‘TIDL’, which has also been
identified in other SUMO-binding proteins [42], appeared to be
more critical than the other two highly conserved ORF61 SIMs.
One possible explanation is the access of SIM-N1 and SIM-N2
sites to SUMO1 might be hindered since they are in a proline-rich
infected skin cells that were stained for ORF23 (red), PML (green), and nuclei (blue). For each panel (left and right), the upper left image shows skin
structures of a parallel section by hematoxylin and eosin (H+E) staining; the upper right image shows epidermal cells from the white square area on
the upper left image (the infected cells were identified by ORF23 expression); the lower images show PML NBs in ORF23-positive cells and
neighboring uninfected cells from the white square area on the upper right image. White arrows indicate cells with abundant nuclear ORF23 protein.
Scale bars: 10 mm. (D) PML NB frequencies (mean6SEM) in pOka- or ORF61 SIM mutants-infected skin cells (pOka, N=153; mSIM-C, N=143; mSIM-
N&C, N=108; ***, p,0.0001 by t-test). (E) PML NB frequencies (mean6SEM) in uninfected skin cells from pOka- or pOka-mSIM-N&C-infected skin
xenografts. Cells from the three major epidermal layers were grouped. Uninfected cells from pOka-infected skin: basal layer cells (N=99), spinous
layer cells (N=79), granular layer cells (N=45). Uninfected cells from pOka-mSIM-N&C-infected skin: basal layer cells (N=109), spinous layer cells
(N=124), granular layer cells (N=39).
doi:10.1371/journal.ppat.1002157.g007
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required for the interaction. Our analysis of ORF61 SIM-C
provides additional evidence that the less conserved ‘TIDL’ motif
can be a functional SIM and demonstrates its role in a viral
SUMO-binding protein.
In previous work, we found that VZV infection in skin causes a
dramatic upregulation of IFN-a in uninfected cells surrounding
VZV lesions and that this response is critical for controlling
infection,asshownbyenhancedVZVreplicationandextensiveskin
lesion formation when the IFN pathway is blocked [39]. We now
report that PML NBs are also increased substantially from an
already high baseline when skin is infected with VZV. Since PML
expression is regulated by IFN, these observations are further
evidence of the significant role of IFN-mediated innate immunity in
skin [39]. Our data indicate that PML NBs are an important
mechanism by which IFN control of VZV infection is achieved in
vivo and that ORF61 SIM-mediated targeting and dispersal of PML
NBs is necessary to counteract this innate response during VZV
pathogenesis. These observations also help to explain why antiviral
immunity was defective in a PML knockout mouse model [8].
The finding that the growth of pOka-mSIM-N&C was severely
defective in skin xenografts, whereas it was indistinguishable from
Figure 8. ORF61 SIM-dependent disruption of PML NBs is not required for VZV replication in cultured cells treated with IFN-a.
(A) Confocal microscopy of mock- or IFN-a-treated melanoma cells that were stained for PML (green) and nuclei (blue) (left and middle panels). Right
panel shows PML NBs (green) in uninfected cells from pOka-infected skin xenografts. Nuclei were stained with Hoechst (blue). Scale bars: 20 mm.
(B) Confocal microscopy of melanoma cells that were treated with IFN-a and then infected with pOka or pOka-mSIM-N&C. Cells were stained for
ORF61 (red), PML (green), and nuclei (blue). The images show PML NBs in cells expressing abundant ORF61 and SIM mutant proteins. Scale bars:
20 mm. (C) Replication of pOka and pOka-mSIM-N&C in melanoma cells (left panel) and HELF cells (right panel) treated with IFN-a. Each point
represents mean6SEM of virus titers from three replicates.
doi:10.1371/journal.ppat.1002157.g008
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the ORF61 SIMs could only be demonstrated when assessed in the
context of VZV replication in differentiated host cells in vivo. The
very high frequencies of PML NBs in differentiated skin cells in vivo
suggests that the abundance of PML NBs determines whether the
ORF61 SIM-mediated effect on PML NBs is necessary for VZV to
achieve efficient replication. PML NB frequencies could not be
enhanced to these levels in cultured cells even with IFN treatment
in vitro. Since PML NBs are also numerous in the nuclei of both
neurons and satellite cells [9], it will be of interest to investigate the
contribution of ORF61 SIM-dependent PML NB disruption in
VZV neuropathogenesis. The need to define functional require-
ments for disrupting PML NBs in vivo was also evident from the
fact that mutating SIM-C alone was sufficient to substantially
affect ORF61 dispersal of PML NBs in cultured cells whereas all
three SIMs were necessary for PML NB disruption in skin.
Another difference between cell culture and skin cells in vivo was
that the mutant ORF61 lacking all SIMs retained some capacity to
associate with PML NBs in cultured cells but the association was
reduced significantly in skin cells. These observations suggest
another VZV protein(s) or VZV-activated cellular factor(s) may
bind to ORF61 and facilitate ORF61 targeting of PML NBs in vitro
but has a limited role in vivo. We speculate that the differential
availability or expression of these factors in skin cells compared to
cultured cells might have contributed to the differential require-
ment of the three ORF61 SIMs to VZV replication in vivo and in
vitro. These questions warrant further investigation, particularly in
the different types of human cells that are targeted during VZV
pathogenesis.
In HSV-infected cells, the ICP0 RING domain acts as an
ubiquitin E3 ligase and triggers proteasome-dependent PML
degradation and PML NB disruption [14,15]. Our experiments
confirmed that the RING domain was also necessary for ORF61-
induced PML NB dispersal but we found that it was dispensable
for ORF61 association with PML NBs. In contrast, the ORF61
SIMs were required for both PML NB association and disruption,
indicating that PML NB dispersal by ORF61 is a two-step process:
the ORF61 SIMs first recognize sumoylated PML protein in PML
NBs and the RING domain is needed to execute dispersal. As was
consistent with the persistent PML protein expression in VZV-
infected cells [9,13], ORF61 expression as a single protein caused
PML NB disruption but PML protein was not degraded; therefore,
we speculate that the ORF61 RING domain has functions other
than E3 ligase that are necessary for its contribution to PML NB
disruption. For example, since RING domains mediate protein-
protein interactions [43], the RING domain in ORF61 may form
a complex with other RING finger proteins in the nucleoplasm
and thereby dislodge ORF61 SIM-bound PML proteins from
PML NBs. However, during other cellular events in which ORF61
is involved, it is quite possible that the ORF61 RING domain acts
as an E3 ligase and mediates its substrate degradation, since
ORF61 RING domain is known to exhibit E3 ligase activity in
vitro [19,20]. It is known that all alphaherpesviruses encode RING
finger proteins related to ICP0 and ORF61 and most of them have
been shown to target PML NB components [44]. Of interest, our
sequence analyses indicate the presence of conserved SIM(s) in
these RING finger proteins. Taken together, we propose that the
interaction of these SIM-containing viral proteins with sumoylated
Figure 9. ORF61 SIMs are not required for VZV replication in non-proliferating cells in vitro. (A) Confocal microscopy of mock-, pOka-, or
pOka-mSIM-N&C-infected skin xenografts that were stained for the proliferation marker Ki67 (green) and nuclei (blue). Scale bars: 100 mm.
(B) Confocal microscopy of normal and serum-starved HELFs that were stained for the proliferation marker Ki67 (green) and nuclei (blue). Scale bars:
100 mm. (C) Replication of pOka and pOka-mSIM-N&C in normal and serum-starved HELFs. Each point represents mean6SEM of virus titers from three
replicates for each virus under normal and serum-starved conditions.
doi:10.1371/journal.ppat.1002157.g009
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PML NB structures for dispersal whereas the RING domain in the
orthologs has variable functions, and these functions determine
whether, or the extent to which, PML protein is degraded. Our
recent experiments in VZV-infected skin cells and neurons showed
that PML protein that persists can form a novel class of PML
nuclear cages with the capacity to sequester newly synthesized
capsids and constitute an intrinsic anti-VZV defense [9]. Viruses
like HSV have the capability to completely overcome the PML-
mediated intrinsic barrier as they not only disrupt PML NBs but
also efficiently degrade PML protein; therefore these viruses may
have an advantage against the IFN defense that is triggered and
amplified within infected tissues. We speculate that this difference
in the effect on PML protein, resulting from the different
functional capacities of ICP0 and ORF61, may help to explain
why HSV reactivates much more frequently than VZV in the
naturally infected host [45]. Of note, the gammaherpesvirus
KSHV-encoded LANA2 protein disperses PML NBs by a SIM-
dependent process in cultured cells although it does not have a
RING domain [36]. We propose that SIM-dependent disruption
of the architecture of PML NBs might be a conserved mechanism
among herpesviruses, independent of the fate of PML protein.
As noted, many viruses encode gene products that have been
shown to modify PML NBs in cultured cells [7]. However, to
define the specific importance of PML NB modulation for viral
replication and pathogenesis, viral mutants that are disabled only
in this function are needed. HSV ICP0 RING domain mutant
viruses do not disrupt PML NBs but the RING domain is also
essential for other ICP0 functions, including viral gene expression,
innate immune evasion and virion formation [46-48]. Therefore, it
is difficult to attribute the replication defect of the HSV ICP0
RING domain mutant to a single function. Experiments with the
ORF61 SIM mutants avoided these concerns because the RING
domain was intact and other functions of ORF61, including viral
gene regulation and NF-kB suppression and ORF61 protein
stability were preserved. These ORF61 functions, such as NF-kB
regulation, are also likely to be important contributions of this
multi-functional protein to VZV pathogenesis and warrant further
investigation [23]. Nevertheless, since ORF61 SIMs might target
many more sumoylated proteins in PML NBs or other nuclear
compartments, other ORF61 SIM-mediated interactions could
contribute to VZV replication in vitro and to pathogenesis in vivo in
addition to their role in PML NB disruption.
In summary, we have demonstrated that VZV ORF61 interacts
with SUMO1 via three conserved SIMs. The interaction was
essential for the association of ORF61 with PML NBs and
ORF61-mediated PML NB disruption in infected skin cells in vivo.
VZV replication and spread in skin tissues in vivo depended on this
ORF61 SIM-mediated function. Our data support the conclusion
that PML NBs provide an intrinsic host defense against VZV
infection in skin, which is an essential stage in VZV pathogenesis
during primary and recurrent infection of the human host and we
have elucidated the ORF61 SIM-dependent mechanism that is
used by VZV to counteract these antiviral nuclear structures.
Materials and Methods
Ethics statement
The human fetal tissues for SCID xenograft studies were
obtained from Advanced Bioscience Resources, Inc. (Alameda,
CA) in accordance with state and federal regulations for tissue
acquisition for biomedical research, in accordance with FDA 21
CFR Part 1271 GTP (Good Tissue Practices), UAGA and NOTA.
Human melanoma cells (a tumor cell line) and primary human
embryonic lung fibroblasts (HELF) were derived and used as
described previously [23]. Animal protocols complied with the
Animal Welfare Act and were approved by the Stanford
University Administrative Panel on Laboratory Animal Care.
Cells
Human melanoma cells (a tumor cell line) and primary human
embryonic lung fibroblasts (HELF) were derived and used as
described previously [23]. The PML knock-down melanoma cell
line (siPML) was a gift from Prof. Saul Silverstein, University of
Columbia and was used as the negative control in PML western
blot experiments.
Chemicals and reagents
Proteasome inhibitor MG132 (Calbiochem) was diluted in
DMSO and used at 10 mM; DMSO was used for mock treatment.
Human tumor necrosis factor a (TNF-a) (Biovision) was used at
20 ng/mL for activation of the NF-kB pathway. Human IFN-a
Hu-IFN-a2b (PBL InterferonSource) was used at 1000 interna-
tional units (IU) per mL for upregulation of PML in melanoma
cells and HELFs.
Antibodies
Rabbit polyclonal antibodies against ORF61 and IE63 were
kindly provided by Prof. Paul Kinchington, University of
Pittsburgh; rabbit polyclonal anti-ORF23 was generated by rabbit
immunization with purified protein [49]. PML antibodies were
mouse monoclonal anti-PML (PG-M3) and rabbit polyclonal anti-
PML (Santa Cruz Biotech). Other antibodies included mouse
monoclonals against SUMO1 (Zymed), VZV gE (Chemicon), and
a-Tubulin (Sigma) and rabbit polyclonal against Ki67 (Abcam).
Plasmids
The ORF61 expression plasmid pcDNA-ORF61 was con-
structed by cloning full-length ORF61 coding sequence into
pcDNA3.1(+). ORF61 DNA was amplified by PCR with forward
primer (ORF61-F) 59-GATCAAGCTTATGGATACCATAT-
TAGCGGG-39 containing a HindIII site and reverse primer
(ORF61-R) 59-GCGAATTCCTAGGACTTCTTCATCTTGT-
39 containing an EcoRI site. The PCR product was digested with
HindIII and EcoRI and ligated to HindIII&EcoRI-digested
pcDNA3.1(+) to generate pcDNA-ORF61. The ORF61(DRING)
fragment, from which amino acids 1-60 were deleted, was am-
plified by PCR with the forward primer (DRING-F) 59-GAT-
CAAGCTTATGGTGCAATCCATCCTGCATAAG-39 contain-
ing the HindIII site and the reverse primer (ORF61-R), and
ligated to HindIII/EcoRI-digested pcDNA3.1(+) to generate
pcDNA-ORF61(DRING). pcDNA constructs expressing ORF61
SIM mutants (pcDNA-mSIM) were constructed by substituting the
four hydrophobic core residues of SIMs with alanines in the
context of pcDNA-ORF61 (SIM-N1, IDIL to AAAA; SIM-N2,
IDLL to AAAA; SIM-C, TIDL to AAAA). Primers used for SIM
mutagenesis are:
SIM-N1: 59-CATTTGAAGATTCCGCTGCCGCTGCACC-
GGGAGATG-39 and 59-CATCTCCCGGTGCAGCGGCAG-
CGGAATCTTCAAATG-39; SIM-N2: 59-CCGGGAGATGT-
CGCAGCTGCTGCGCCACCAAGCCCA-39 and 59-TGGGC-
TTGGTGGCGCAGCAGCTGCGACATCTCCCGG-39; SIM-
C: 59-CGATGCTTAGCAGCAGCCGCGACATCTGAGTCT-
GA-39 and 59-TCAGACTCAGATGTCGCGGCTGCTGC-
TAAGCATCG-39
PML mammalian expression plasmids were kind gifts from Prof.
Peter Hemmerich, Leibnitz-Institute of Age Research, Germany
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The NF-kB reporter plasmid was gift from Prof. Dingxiang Liu in
Institute of Molecular and Cell Biology, Singapore. The gE
promoter luciferase construct was as described [50]. All constructs
were confirmed by nucleotide sequencing (Elim Biopharm, Inc.,
Hayward, CA).
GST pull down
ORF61-transfected cells or VZV-infected cells grown on 10 cm
dishes were lysed in 100 ul high salt buffer (20 mM HEPES
[pH 7.2], 450 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40, 20%
Glycerol) supplemented with EDTA-free protease inhibitor
cocktail (Roche). Insoluble proteins were removed by centrifuga-
tion. The supernantant was combined with 400 ul NaCl-free
buffer (20 mM HEPES [pH 7.2], 1.5 mM MgCl2, 0.5% NP-40,
20% glycerol) and centrifuged again before GST pull down. GST
or GST-SUMO1/2 proteins (5 mg) (Boston Biochem) were added
to the pre-cleared lysate and rotated at 4uC for 2 h. Glutathione
Sepharose beads (GE Healthcare) were added subsequently and
incubated at 4uC for 2 h. Beads were washed 4 times with the
binding buffer (20 mM HEPES [pH 7.2], 90 mM NaCl, 1.5 mM
MgCl2, 0.5% NP-40, 20% glycerol) and eluted with SDS sample
buffer. The ORF61 protein that bound to the beads was analyzed
by Western blot using the ORF61 antibody and the GST and
GST-SUMO1/2 proteins that bound to the beads was analyzed
by amido black staining.
Cosmid mutagenesis and generation of ORF61 SIM
mutant viruses
Recombinant viruses were generated using cosmids derived
from pOka [51]. The entire pOka genome is covered by four
overlapping cosmids designated Fsp73 (pOka nucleotides [nt] 1 to
33128), Spe14 (pOka nt 21795 to 61868), Pme2 (pOka nt 53755 to
96035), and Spe23 (pOka nt 94055 to 125124). The ORF61
coding region is located in the unique long region in the cosmid
Spe23 (pOka nt 103045-104445). A 4.8 kb PstI-PmlI fragment
containing full length ORF61 gene was subcloned into pCR4-
TOPO (Invitrogen, Inc.) to make pCR4-(PstI/PmlI), in which
ORF61 SIM mutations were generated using two round PCR
method. The PstI-PmlI fragments containing ORF61 SIM
mutations were cloned into pLit(ORF59-65) [23]. Mutant Spe23
cosmids were made by ligating the NheI-AvrII fragment from
pLit(ORF59-65) to Spe23 digested with NheI/AvrII.
Recombinant viruses, designated pOka-mSIM-N, pOka-
mSIM-C, and pOka-mSIM-N&C, were isolated by transfection
of melanoma cells with the mutated Spe23 cosmid and the other
three intact cosmids, Fsp73, Spe14, and Pme2. Genomic DNA
was extracted from virus-infected melanoma cells or HELFs with
DNAzol reagent (Invitrogen, Carlsbad, CA). A PCR fragment
covering the mutated region was amplified from the genomic
DNA using Taq polymerase (Invitrogen) and sequenced (Elim
Biopharm, Inc., Hayward, CA) to confirm mutations.
Virus growth kinetics and infectious focus assay
Melanoma cells (10
6/well) were seeded in a 6-well plate,
infected with 1610
3 PFU/well at day 0, and cultured for 5 days.
On each day, cells from one well were trypsinized, centrifuged,
and resuspended in 1 mL of culture medium. The infected cells
were serially diluted 10-fold, and 0.1 mL was added to melanoma
cells in 24-well plates in triplicate. Cells were fixed in 4%
paraformaldehyde and stained with polyclonal anti-VZV human
immune serum and secondary anti-human biotin (Vector Lab,
Burlingame, CA). The staining was developed with the Fast Red
substrate (Sigma). Statistical analysis of growth kinetics was done
by the Student’s t test.
Infection of skin xenografts in SCIDhu mice
Skin xenografts were made in homozygous CB-17
scid/scid mice,
using human fetal tissue supplied by Advanced Bioscience
Resources (ABR, Alameda, CA) according to federal and state
regulations; the methods used to engraft and infect the skin
xenografts were as described previously (25). Animal use was in
accordance with the Animal Welfare Act and approved by the
Stanford University Administrative Panel on Laboratory Animal
Care. pOka and ORF61 SIM mutant viruses were passed three
times in primary HELF and titered before inoculation. Skin
xenografts were harvested at day 10 and 21 and titers were
determined by infectious focus assay. DNA was extracted from
skin tissues with proteinase K and phenol chloroform (Invitrogen,
Carlsbad, CA). PCR and sequencing were performed to confirm
the expected mutations.
Immunofluorescence and PML NB quantification
Cells seeded on 12 mm glass cover slips were fixed with 4%
paraformaldehyde for 15 min and permeablized with 0.5% Triton-
X100 for 10 min. For dual staining of ORF61 and PML proteins,
cells were incubated with ORF61 rabbit polyclonal antibody (1:200
dilution) and PML mouse monoclonal antibody PG-M3 (1:50
dilution) in blocking buffer (PBS with 5% fetal bovine serum) at
room temperature (RT) for 1 h, followed by incubation with
Alexflour 488 donkey anti-mouse immunoglobulin (Invitrogen) and
Texas Red-conjugated donkey anti-rabbit immunoglobulin (Jack-
son ImmunoResearch) for 30 min. Cell nuclei were stained with
2 mg/mL Hoechst33342 for 10 min after secondary antibody
incubation. All images were obtained with a SP2 Leica confocal
microscope. Images were taken in a fixed setting with the 63x
objective in PML NB number quantification experiments, and with
the 100x objective to quantify the association between ORF61
puncta and PML NBs in infected skin cells.
For skin experiments, sections (5 mm) were made from formalin-
fixed, paraffin-embedded skin tissues. After deparaffinization and
rehydration, sections were treated with citrate-based antigen
unmasking solution (Vector labs) and stained with specific
antibodies (anti-PML [PG-M3], 1:10; anti-ORF61, 1:25; anti-
ORF23, 1:100). Skin sections were examined for cell proliferation
using Ki67 antibody (Abcam).
Immunohistochemistry
Skin sections were stained with VZV gE antibody (Chemicon,
1:2000) and IHC immunoperoxidase secondary detection system
(Chemicon). Staining was developed with Vector VIP substrate kit
and methyl green counterstain (Vector labs).
IFN sensitivity assay
Melanoma cells or HELFs were seeded at 5610
5 cells/well in 6-
well plates. Cells in each well were mock-treated or treated with
1000 IU of Hu-IFN-a2b (PBL InterferonSource) for 24 h prior to
inoculation. Cells were inoculated with 500 PFU/wellof either pOka
or pOka-mSIM-N&C. The media was aspirated at 2 h post-infection
to remove the inoculum and replaced with media with or without
1000 IU of IFN-a2b. Virus titers from 2 h to 36 h post-inoculation
were determined by infectious focus assay on melanoma cells.
Serum starvation assay
HELFs were seeded at 5610
5 cells/well in 6-well plates and at
2610
5 cells/well in 2-well chamber slides. Cells were starved in
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50 PFU/cm
2 of pOka or mSIM-N&C. At 2 hours post infection,
the inoculum was removed and the medium was replaced with
normal medium or serum-free medium. Virus titers in cells
recovered from the 6-well plates at intervals of 2 h to 36 h post-
inoculation were determined by infectious focus assay on
melanoma cells. Cells on chamber slides were fixed with
paraformaldehyde and stained with VZV gE (Chemicon) and
Ki67 (Abcam) antibodies.
Transfection and infection of cultured cells
All transfections were performed with Lipofectamine 2000
(Invitrogen, Carlsbad, CA) following the manufacturer’s instruc-
tions. The transfected cells for immunofluorescence were fixed at
24 h post-transfection. To prepare heavily infected cells for
Western blot analysis of PML proteins, melanoma cells and
HELFs were inoculated with pOka or ORF61 SIM mutants at a
ratio of 1 infected cell:100 uninfected cells. At 24 h post-
inoculation, each cell monolayer was resuspended by trypsiniza-
tion and re-plated on the same dish and left for another 24 h. The
percentage of infected cells was examined by immunofluorescence
with ORF23 antibody and was .90% at the time of harvest. To
prepare infected cells for immunofluorescence microscopy, cells
growing on glass coverslips were inoculated with pOka or ORF61
SIM mutants at a ratio of 1 infected cell: 1000 uninfected cells and
infected for 24 h.
Western blot
Transfected or infected cells growing on 6-well plates were lysed
in high salt buffer as described above. Proteins were separated on
SDS-PAGE gels and transferred to polyvinylidene difluoride
(PVDF) membrane (Millipore, Bedford, MA) with a semidry
transfer cell (Bio-Rad). The membranes were blocked for 1 h in
5% non-fat milk in PBST (1x PBS plus 0.1% Tween-20),
incubated with primary antibody at RT for 2 h, washed three
times with PBST, incubated with horseradish peroxidase-conju-
gated rabbit or mouse immunoglobulin (Amersham) at RT for
1 h, and washed three times with PBST. Proteins were detected
using the enhanced chemiluminescence plus detection system
(Amersham).
Luciferase assay
Melanoma cells were seeded in 24-well plates one day before
transfection. Three independent transfections were preformed for
each experiment. In the gE and ORF61 promoter assay, 900 ng of
the promoter construct was transfected to melanoma cells with
100 ng of pcDNA-ORF61 or pcDNA-mSIM or empty vector for
24 h. In NF-kB experiments, 500 ng of NF-kB reporter plasmid
was cotransfected with 250 ng of pcDNA-ORF61 or pcDNA-
mSIM or empty vector; at 24 h post-transfection, cells were
treated with 20 ng/mL TNF-a for 6 h before cell lysis and
luciferase assay. In the NF-kB dose-dependent experiment,
increasing amounts of pcDNA-ORF61 or pcDNA-ORF61(DR-
ING) (10 ng, 50 ng, and 250 ng) were used and the total DNA was
brought to 850 ng with empty vector. In all transfections, 0.07 ng
of the plasmid pRL-TK(–) in which TK promoter has been
removed was included to normalize the transfection efficiency.
Luciferase assays were performed using the dual luciferase kit
(Promega) according to the manufacturer’s recommendations.
Accession numbers
VZV ORF61: NP_040183; VZV ORF23: AAY57709.1; VZV
IE63: Q77NN7; VZV gE: Q9J3M8.
Supporting Information
Figure S1 PML expression in uninfected and infected
cells from pOka- or pOka-mSIM-N&C-infected skin
xenografts. Confocal microscopy of pOka- or pOka-mSIM-
N&C-infected skin xenografts that were stained for ORF23 (red),
PML (green), and nuclei (blue).
(TIF)
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